Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 7
Submit an article Journal homepage
405
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasia

Elizabeth DiMaggioDepartment of Pharmacy, Moffitt Cancer Center, Tampa, FL, USA; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-8745-7753
ORCID Icon,
Jun-Min ZhouBiostatistics Core, Moffitt Cancer Center, Tampa, FL, USA;
,
Ryan CaddellDepartment of Pharmacy, Moffitt Cancer Center, Tampa, FL, USA;
,
Rebecca TomblesonDepartment of Pharmacy, Moffitt Cancer Center, Tampa, FL, USA;
,
Janelle PerkinsCollege of Pharmacy, University of South Florida, Tampa, FL, USA;
,
Claudio AnasettiDepartment of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA;
,
Farhad KhimaniDepartment of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA;
,
Joseph PidalaDepartment of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA;
,
Taiga NishihoriDepartment of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA;
,
Lia PerezDepartment of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA;
,
Brian BettsDepartment of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA;
,
Hugo F. FernandezMoffitt Malignant Hematology and Cellular Therapy at Memorial Healthcare System, Pembroke Pines, FL, USA
&
Asmita MishraDepartment of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA;
show all
Pages 1678-1687 | Received 26 Oct 2019, Accepted 11 Feb 2020, Published online: 05 Mar 2020

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Alexandra Gomez-Arteaga & Koen van Besien. (2022) Allogeneic transplant graft source – conditioning – GVHD prophylaxis: don’t mix and match!. Leukemia & Lymphoma 63:1, pages 7-9.
Read now
Jingmei Hsu, Koen Van Besien & Frédéric Baron. (2020) Busulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation?. Leukemia & Lymphoma 61:7, pages 1529-1534.
Read now

Articles from other publishers (4)

Francesca Guijarro, Alex Bataller, Marina Diaz-Beyá, Ana Garrido, Christelle Coll-Ferrà, Susana Vives, Olga Salamero, David Valcárcel, Mar Tormo, Montserrat Arnan, Antònia Sampol, Sandra Castaño-Díez, Carmen Martínez, María Suárez-Lledó, Francesc Fernández-Avilés, Juan Carlos Hernández-Boluda, Josep Maria Ribera, Montserrat Rovira, Salut Brunet, Jorge Sierra & Jordi Esteve. (2022) Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan. Bone Marrow Transplantation 57:8, pages 1304-1312.
Crossref
Jade L. Kutzke, Julianna A. Merten, Amanda G. Pawlenty, Erin F. Barreto, Gabe T. Bartoo, Kristin C. Mara, Mark R. Litzow, William J. Hogan, Mithun V. Shah, Abhishek A. Mangaonkar, Nelson Leung & Hassan B. Alkhateeb. (2022) Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioning. Blood Advances 6:13, pages 3844-3849.
Crossref
Arnaud Campidelli, Marie Robin, Thomas Remen, Amandine Luc, Hélène Labussière-Wallet, Rémi Dulery, Micha Srour, Patrice Ceballos, Edouard Forcade, Stephanie Nguyen-Quoc, Sabine Furst, Pascal Turlure, Jacques-Olivier Bay, Célestine Simand, Ambroise Marçais, Etienne Daguindau, Marie-Thérèse Rubio & Maud D'Aveni. (2022) On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation. Clinical Lymphoma Myeloma and Leukemia 22:1, pages 34-43.
Crossref
Betül Oran, Kwang Woo Ahn, Caitrin Fretham, Amer Beitinjaneh, Asad Bashey, Attaphol Pawarode, Baldeep Wirk, Bart L. Scott, Bipin N. Savani, Christopher Bredeson, Daniel Weisdorf, David I. Marks, David Rizzieri, Edward Copelan, Gerhard C. Hildebrandt, Gregory A. Hale, Hemant S. Murthy, Hillard M. Lazarus, Jan Cerny, Jane L. Liesveld, Jean A. Yared, Jean Yves-Cahn, Jeffrey Szer, Leo F. Verdonck, Mahmoud Aljurf, Marjolein van der Poel, Mark Litzow, Matt Kalaycio, Michael R. Grunwald, Miguel Angel Diaz, Mitchell Sabloff, Mohamed A. Kharfan-Dabaja, Navneet S. Majhail, Nosha Farhadfar, Ran Reshef, Richard F. Olsson, Robert Peter Gale, Ryotaro Nakamura, Sachiko Seo, Saurabh Chhabra, Shahrukh Hashmi, Shatha Farhan, Siddhartha Ganguly, Sunita Nathan, Taiga Nishihori, Tania Jain, Vaibhav Agrawal, Ulrike Bacher, Uday Popat & Wael Saber. (2021) Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes. Transplantation and Cellular Therapy 27:11, pages 921.e1-921.e10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.